BlackRock’s Sonoma Pharmaceuticals SNOA Stock Holding History

BlackRock’s Portfolio SNOA Stock Details SNOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$139	Hold	113	–	–	﹤0.01%	5606
2026 Q1	$241	Hold	113	–	–	﹤0.01%	5589
2025 Q4	$411	Hold	113	–	–	﹤0.01%	5441
2025 Q3	$438	Hold	113	–	–	﹤0.01%	5369
2025 Q2	$321	Hold	113	–	–	﹤0.01%	5387
2025 Q1	$247	Hold	113	–	–	﹤0.01%	5367
2024 Q4	$304	Hold	113	–	–	﹤0.01%	5338
2024 Q3	$347	Hold	113	–	–	﹤0.01%	5165
2024 Q2	$481	Hold	113	–	–	﹤0.01%	5222
2024 Q1	$377	Hold	113	–	–	﹤0.01%	5227
2023 Q4	$409	Sell	113 -31	-22%	-$198	﹤0.01%	5296
2023 Q3	$2.22K	Hold	144	–	–	﹤0.01%	5295
2023 Q2	$3.08K	Hold	144	–	–	﹤0.01%	5347
2023 Q1	$2.81K	Hold	144	–	–	﹤0.01%	5421
2022 Q4	$3.22K	Hold	144	–	–	﹤0.01%	5567
2022 Q3	$6K	Hold	144	–	–	﹤0.01%	5622
2022 Q2	$9K	Hold	144	–	–	﹤0.01%	5640
2022 Q1	$11K	Hold	144	–	–	﹤0.01%	5631
2021 Q4	$13K	Hold	144	–	–	﹤0.01%	5587
2021 Q3	$16K	Hold	144	–	–	﹤0.01%	5423
2021 Q2	$21K	Sell	144 -28	-16%	-$4.39K	﹤0.01%	5286
2021 Q1	$26K	Hold	172	–	–	﹤0.01%	4997
2020 Q4	$25K	Hold	172	–	–	﹤0.01%	4756
2020 Q3	$29K	Hold	172	–	–	﹤0.01%	4669
2020 Q2	$24K	Hold	172	–	–	﹤0.01%	4672
2020 Q1	$17K	Hold	172	–	–	﹤0.01%	4645
2019 Q4	$15K	Hold	172	–	–	﹤0.01%	4695
2019 Q3	$20K	Hold	172	–	–	﹤0.01%	4651
2019 Q2	$27K	Buy	172 +3	+2%	+$461	﹤0.01%	4650
2019 Q1	$29K	Buy	169 +2	+1%	+$303	﹤0.01%	4550
2018 Q4	$21K	Buy	167 +4	+2%	+$798	﹤0.01%	4582
2018 Q3	$43K	Hold	163	–	–	﹤0.01%	4562
2018 Q2	$72K	Buy	163 +2	+1%	+$1.3K	﹤0.01%	4513
2018 Q1	$106K	Buy	161 +1	+0.6%	+$822	﹤0.01%	4332
2017 Q4	$157K	Buy	160 +2	+1%	+$1.71K	﹤0.01%	4264
2017 Q3	$149K	Buy	158 +2	+1%	+$2.17K	﹤0.01%	4294
2017 Q2	$186K	Buy	156 +3	+2%	+$3.7K	﹤0.01%	4266
2017 Q1	$198K	Buy	+153	New	+$178K	﹤0.01%	4215

Other funds holding SNOA

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MCWS

McKinley Carter Wealth Services Wheeling, West Virginia $1.94B AUM 20.7% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

GRP

Global Retirement Partners San Rafael, California $6.54B AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return

QWM

Quaker Wealth Management Moorestown, New Jersey $344M AUM 15.21% 1-Year Est. Return

BlackRock's SNOA Position: Q2 2026 in Review

BlackRock held its Sonoma Pharmaceuticals (SNOA) position steady in Q2 2026 at 113 shares worth $139. The position accounts for ﹤0.01% of the portfolio, ranked #5606.

BlackRock first reported a position in SNOA in Q1 2017 and has held it in 38 quarters since. The position peaked at $198K in Q1 2017. 12 funds tracked by Wall St. Rank hold SNOA as of Q2 2026.

BlackRock held 113 shares of Sonoma Pharmaceuticals worth $139 as of Q2 2026.
BlackRock left its Sonoma Pharmaceuticals share count unchanged in Q2 2026.
Sonoma Pharmaceuticals made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #5606 holding.
BlackRock first reported a position in Sonoma Pharmaceuticals in Q1 2017 and has held it in 38 quarters since.
BlackRock's Sonoma Pharmaceuticals position peaked at $198K in Q1 2017.
12 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.